Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AdvaMed lauds DME legislation

This article was originally published in The Gray Sheet

Executive Summary

The Medicare Durable Medical Equipment Access Act of 2005 will ensure continued Medicare beneficiary access to medical technologies in a competitive bidding process, trade association says in Sept. 12 letter of support. Introduced July 28, the bill (HR 3559) adds patient protections to the Medicare Modernization Act (1"The Gray Sheet" Aug. 8, 2005, In Brief). AdvaMed commends the inclusion of quality standards in the competitive acquisition process and the demand for evidence, prior to implementation, that the program will generate at least 10% in savings. The group also praises measures to ensure equal opportunity for small businesses. CMS' proposed rule on DME competitive bidding is expected this fall...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT022656

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel